The $15 billion ad-powered AI startup your doctor may already be using
Summary
Ars Technica reports on OpenEvidence, a controversial $15 billion ad-supported AI startup used by a majority of US doctors to search medical literature and guidance. The piece highlights strong physician adoption, significant investment, and a valuation tied to ad revenue, while raising questions about accuracy, regulatory compliance, and the sustainability of an ad-backed model in healthcare. It also covers mixed study results and competitive pressure from larger AI players, along with ongoing plans for clinical trials and drug-discovery initiatives.